JAC Advance Access published online on December 14, 2005
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dki444
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Medicine, Section of Infectious Diseases, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030, USA
* To whom correspondence should be addressed. The institution of highly active antiretroviral therapy (HAART) in HIV-infected patients restores protective immune responses against a wide variety of pathogens and dramatically decreases mortality. In a subset of patients receiving HAART, immune reconstitution is associated with a pathological inflammatory response leading to substantial short-term morbidity and even mortality. The past several years have seen marked advances in our clinical understanding of the immune reconstitution inflammatory syndrome (IRIS), but many questions remain. This article summarizes recent data on clinical risk factors for the development of IRIS. A consistent finding from multiple groups is that IRIS develops in a substantial percentage of HIV-infected patients who have an underlying opportunistic infection and receive HAART. As the use of HAART stands to markedly increase over the next several years, optimal care of patients receiving HAART will need to incorporate monitoring for and treating complications of IRIS.
Leading article
Immune reconstitution inflammatory syndrome: more answers, more questions
Samuel A. Shelburne 1,
Martin Montes 1,
and
Richard J. Hamill 2 *
2 Department of Medicine, Section of Infectious Diseases, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030, USA; Department of Medicine, Section of Infectious Diseases (111G), Michael E. DeBakey Veterans Affairs Medical Center, 2002 Holcombe Boulevard, Houston, TX 77030, USA
Richard J. Hamill, E-mail: richard.hamill{at}med.va.gov
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
G. Pfeffer, A. Prout, J. Hooge, and J. Maguire BIOPSY-PROVEN IMMUNE RECONSTITUTION SYNDROME IN A PATIENT WITH AIDS AND CEREBRAL TOXOPLASMOSIS Neurology, July 28, 2009; 73(4): 321 - 322. [Full Text] [PDF] |
||||
![]() |
P. De Beaudrap, J.-F. Etard, A. Diouf, I. Ndiaye, N. F. Gueye, P. M. Gueye, P. S. Sow, S. Mboup, I. Ndoye, R. Ecochard, et al. Modeling CD4+ Cell Count Increase Over a Six-Year Period in HIV-1-Infected Patients on Highly Active Antiretroviral Therapy in Senegal Am J Trop Med Hyg, June 1, 2009; 80(6): 1047 - 1053. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. McCombe, R. N. Auer, F. G. Maingat, S. Houston, M. J. Gill, and C. Power Neurologic immune reconstitution inflammatory syndrome in HIV/AIDS: Outcome and epidemiology Neurology, March 3, 2009; 72(9): 835 - 841. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Klotz, A. Aziz Mohammed, M. Girmai Woldemichael, M. Worku Mitku, and M. Handrich Immune Reconstitution Inflammatory Syndrome in a Resource-Poor Setting J Int Assoc Physicians AIDS Care (Chic Ill), March 1, 2009; 8(2): 122 - 127. [Abstract] [PDF] |
||||
![]() |
M. J. Rosen Pulmonary Complications of HIV Infection ACCP Pulmonary Med Brd Rev, January 1, 2009; 25(0): 219 - 232. [Full Text] [PDF] |
||||
![]() |
J. S. Rogers, S. Zakaria, K. A. Thom, K. M. Flammer, M. Kanno, and M. R. Mehra Immune Reconstitution Inflammatory Syndrome and Human Immunodeficiency Virus-Associated Myocarditis Mayo Clin. Proc., November 1, 2008; 83(11): 1275 - 1279. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Lawn, R. J. Wilkinson, M. C. I. Lipman, and R. Wood Immune Reconstitution and "Unmasking" of Tuberculosis during Antiretroviral Therapy Am. J. Respir. Crit. Care Med., April 1, 2008; 177(7): 680 - 685. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ji, F. Rintelen, C. Waltzinger, D. Bertschy Meier, A. Bilancio, W. Pearce, E. Hirsch, M. P. Wymann, T. Ruckle, M. Camps, et al. Inactivation of PI3K{gamma} and PI3K{delta} distorts T-cell development and causes multiple organ inflammation Blood, October 15, 2007; 110(8): 2940 - 2947. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Serpa, A. Moran, J. C. Goodman, T. P. Giordano, and A. C. White Jr Neurocysticercosis in the HIV Era: A Case Report and Review of the Literature Am J Trop Med Hyg, July 1, 2007; 77(1): 113 - 117. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Zavascki Comment on: Immune reconstitution inflammatory syndrome: more answers, more questions J. Antimicrob. Chemother., November 1, 2006; 58(5): 1094 - 1094. [Full Text] [PDF] |
||||
![]() |
S. A. Shelburne, M. Montes, and R. Hamill Immune reconstitution inflammatory syndrome: more answers, more questions--authors' response J. Antimicrob. Chemother., November 1, 2006; 58(5): 1094 - 1095. [Full Text] [PDF] |
||||
![]() |
L. McKinley, A. J. Logar, F. McAllister, M. Zheng, C. Steele, and J. K. Kolls Regulatory T Cells Dampen Pulmonary Inflammation and Lung Injury in an Animal Model of Pneumocystis Pneumonia J. Immunol., November 1, 2006; 177(9): 6215 - 6226. [Abstract] [Full Text] [PDF] |
||||








